The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament. In particular, the compound may be used as a preferential agonist of Cannabinoid Receptor 2.
申请公布号
DK2771327(T3)
申请公布日期
2017.01.16
申请号
DK20120778342T
申请日期
2012.10.25
申请人
F.HOFFMANN-LA ROCHE AG
发明人
BISSANTZ, Caterina;DHURWASULU, Baledi;GRETHER, Uwe;HAZRA, Anindya;Hebeisen, Paul;ROEVER, Stephan;ROGERS-EVANS, Mark
